Clinical Trial Update: Safety and Efficacy Study Using 5-ALA Oral Administration as an Adjuvant Therapy on the Rate of Local Tumor Recurrence in Patients Who Have Desmoids Tumors [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating oral 5-aminolevulinic acid photodynamic therapy as an adjuvant treatment to reduce local recurrence after surgical resection i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Desmoid Tumor
• Desmoid-type Fibromatosis

Drugs mentioned

• 5-ALA (5-aminolevulinic acid)

Snippet

Sponsor: michal roll | Conditions: The Aim of the Study is to Evaluate the Efficacy of Photodynamic Therapy as an, Adjuvant Therapy on the Clinical Outcome of Patients With Desmoid Tumors After | Phase 2 | Status: RECRUITING